This product is a recombinant mouse anti-HIV-1 monoclonal antibody (G3-4). G3-4 specifically binds to gp120 and can be potentially used in the treatment studies of acquired immunodeficiency syndrome (AIDS), a condition in humans characterized by clinical features including wasting syndromes, central nervous system degeneration and profound immunosuppression that results in life-threatening opportunistic infections and malignancies.
Figure 1 Inhibitory activity of antibodies on sCD4-gpl2O binding. mAbs were G3-4 (v), 15e (A), G3-519 (o), and BAT123 (o).
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 2 Reactivity of mAb G3-4 with two HIV-1 isolates (Ille and RF) by radioimmunoprecipitation assay (A) and immunofluorescence and analyzed by flow cytometry (B).
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 3 Neutralizing activity of mAb G3-4 against laboratory isolates: "IB (o), RF (A), and MN (0).
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 4 Radioimmunoprecipitation assay of mAb G3-4 reactivity with HIV-1 lysate reduced with dithiothreitol.
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 5 Slot-blot immunoassays of mAbs G3-4, I5e, and BAT123 reactivity with the III gpl20 in the presence of (+) or the absence of (-) dithiothreitol (DTT) reduction. PC, positive-control human serum.
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 6 Inhibitory activity of mAbs G34 (A), BAT123 (o), G3-519 (e), and 15e (o) on the binding of biotinylated mAb G3-4 to captured 111B gpl20.
Another discontinuous epitope on glycoprotein gpl20 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody
Figure 7 Precipitation of the WT and DV3 mutant envelope glycoproteins by gp120-specific mAbs.
COS-1 cell transfectants expressing either WT or DV3 gp120 were lysed in NP-40 buffer and precipitated with the indicated mAbs in the presence or absence of 50 mg/ml of CRDS.
Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes
Figure 8 Immunoprecipitation of envelope glycoproteins of HIV-1 clones.
The radiolabeled cell lysates were coprecipitated with anti-MHC class I mAb W6/32 to ensure loading equivalent amounts of protein. Results are representative of three separate experiments.
Role of the V2, V3, and CD4-Binding Domains of GP120 in Curdlan Sulfate Neutralization Sensitivity of HIV-1 during Infection of T Lymphocytes
Figure 9 ELISA binding curves of select anti-gp120 Abs against full-length and loop-deleted constructs of gp140JR-FL.
Full-length (diamonds), V1-deleted (squares), V2-deleted (triangles), and V3-deleted (x) gp140JR-FL were captured via the C-terminal region of gp120 with the sheep Ab D7324 and probed with pooled HIVIG, 2G12, Fab AH48, G3-4, G3-519, G3-42, G3-299, and 4KG5. The detection reagents were ABTS for 4KG5 and AP staining solution for all other Abs.
A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12
Figure 10 ELISA inhibition curves of 4KG5 with various MAbs against gp120JR-FL.
A concentration of 4KG5 previously determined to result in approximately 75% of the maximal signal (∼0.3 μg/ml) was coincubated with various concentrations of b12 Fab (squares), b12 IgG (open diamonds), b6 Fab (circles), sCD4 (triangle), AH48 Fab (filled diamonds), or G3-4 IgG (X), and the level of 4KG5 binding to immobilized gp̶¹²⁰JR-FL was measured via the hexahistidine tag of 4KG5 by using the India-HIS probe (Pierce) as a secondary reagent.
A Novel Human Antibody against Human Immunodeficiency Virus Type 1 gp120 Is V1, V2, and V3 Loop Dependent and Helps Delimit the Epitope of the Broadly Neutralizing Antibody Immunoglobulin G1 b12
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-135 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone PGT135) | ELISA, Neut | Human IgG |
PABL-142 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 412d) | Neut, WB, ELISA, FuncS | Human IgG |
PABL-155 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC03) | WB, ELISA, Neut, FuncS | Human IgG |
PABL-156 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC-CH31) | WB, ELISA, Neut, FuncS | Human IgG |
PABL-160 | Mouse Anti-HIV-1 gp120 Recombinant Antibody (clone 59.1) | WB, ELISA, FuncS | Mouse IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-028LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (L91C2) | ELISA | Single domain antibody |
MRO-029LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (L91F10) | ELISA | Single domain antibody |
MRO-030LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (L91E1) | ELISA | Single domain antibody |
MRO-031LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (L91B5) | ELISA | Single domain antibody |
MRO-032LC-VHH | Anti-HIV-1 gp120 Recombinant Antibody (L91H9) | ELISA | Single domain antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-125LC | Anti-HIV-1 gp120 Recombinant Antibody (N6) | Neut, ELISA | Human antibody |
MRO-130LC | Human Anti-HIV-1 gp120 Recombinant Antibody (MRO-130LC) | ELISA, Neut, SPR | Human IgG |
MRO-136LC | Anti-HIV-1 gp120 Recombinant Antibody (Ab900973) | ELISA | Human antibody |
MRO-137LC | Anti-HIV-1 gp120 Recombinant Antibody (Ab900972) | ELISA | Human antibody |
MRO-138LC | Anti-HIV-1 gp120 Recombinant Antibody (Ab900990) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-135LC | Anti-HIV-1 gp120 Recombinant Antibody (CAG1-51-4) | ELISA, WB, Neut | Chimeric antibody (mouse/human) |
MRO-135LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (CAG1-51-4) | ELISA, WB | Chimeric antibody (mouse/human) |
MRO-135LC-F(E) | Anti-HIV-1 gp120 Recombinant Antibody Fab Fragment (CAG1-51-4) | ELISA, WB | Chimeric antibody (mouse/human) |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-041LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (D59/A2) | ELISA | Mouse antibody |
MRO-042LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (F58/H3) | ELISA | Mouse antibody |
MRO-043LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (P1/D12) | ELISA | Mouse antibody |
MRO-044LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (P4/D10) | ELISA | Mouse antibody |
MRO-045LC-S(P) | Anti-HIV-1 gp120 Recombinant Antibody scFv Fragment (A47/B1) | ELISA | Mouse antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-4220 | Rabbit Anti-HIV-1 gp120 Recombinant Antibody (clone SI299DS) | WB, ELISA | Rabbit IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-3299CQ-F(E) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone L41); Fab Fragment | Neut, ELISA | Human Fab |
MRO-3384CQ-F(E) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC26.09 (CAP256-VRC26.09,CAP256.09)); Fab Fragment | ELISA, Neut | Human Fab |
MRO-3385CQ-F(E) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC26.10 (CAP256-VRC26.10)); Fab Fragment | ELISA, Neut | Human Fab |
MRO-3386CQ-F(E) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC26.11 (CAP256-VRC26.11)); Fab Fragment | ELISA, Neut | Human Fab |
MRO-3387CQ-F(E) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone VRC26.12 (CAP256-VRC26.12)); Fab Fragment | ELISA, Neut | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PSBC-291 | Human Anti-HIV-1 gp120 Recombinant Antibody (clone 1A8); scFv Fragment | Neut | Human scFv |
HPAB-0713-YJ-S(P) | Monkey Anti-gp120 Recombinant Antibody (GE331); scFv Fragment | ELISA, Neut | Monkey scFv |
HPAB-0714-YJ-S(P) | Monkey Anti-gp120 Recombinant Antibody (GE443); scFv Fragment | ELISA | Monkey scFv |
HPAB-0716-YJ-S(P) | Monkey Anti-gp120 Recombinant Antibody (2S1H3); scFv Fragment | ELISA, IHC | Monkey scFv |
PABJ-0086-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone DH677.3); scFv Fragment | ELISA, ADCC | Human scFv |
CAT | Product Name | Application | Type |
---|---|---|---|
PABX-101-S(P) | Human Anti-HIV-1 gp120 Recombinant Antibody (clone PG9); scFv Fragment | WB, ELISA, FuncS | Human scFv |
There are currently no Customer reviews or questions for MRO-150LC. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.